Company Filing History:
Years Active: 2019
Title: Eric Weterings: Innovator in Cancer Therapeutics
Introduction
Eric Weterings is a notable inventor based in Tucson, Arizona. He has made significant contributions to the field of cancer research through his innovative work on small molecule inhibitors. His research focuses on addressing conditions involving aberrant Ku70/80 activity, which plays a crucial role in cancer progression.
Latest Patents
Weterings holds a patent titled "Small molecule inhibitors of Ku70/80 and uses thereof." This patent provides methods for identifying and treating subjects with conditions related to Ku70/80 activity. The invention specifically relates to small molecules that inhibit the Ku70/80 protein and the non-homologous end-joining (NHEJ) pathway. These inhibitors have potential therapeutic applications for treating cancer and other diseases.
Career Highlights
Eric Weterings is affiliated with the University of Arizona, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment. With one patent to his name, he is recognized for his innovative approach to addressing complex medical challenges.
Collaborations
Weterings collaborates with esteemed colleagues, including Daruka Mahadevan and Josef Vagner. Their combined expertise enhances the research efforts at the University of Arizona, contributing to advancements in cancer therapeutics.
Conclusion
Eric Weterings is a pioneering inventor whose work on small molecule inhibitors has the potential to transform cancer treatment. His contributions to the field highlight the importance of innovation in addressing critical health challenges.